Detalles de la búsqueda
1.
Short report: Characterizing HIV care among a clinical sample of transgender women living with HIV.
HIV Med
; 23(4): 324-330, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35193172
2.
Characteristics and outcomes of antiretroviral-treated HIV-HBV co-infected patients in Canada?
BMC Infect Dis
; 19(1): 982, 2019 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31752729
3.
Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients.
BMC Infect Dis
; 17(1): 266, 2017 04 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28399819
4.
Predictors of viral suppression and rebound among HIV-positive men who have sex with men in a large multi-site Canadian cohort.
BMC Infect Dis
; 16(1): 590, 2016 Oct 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27769246
5.
Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054).
HIV Clin Trials
; 16(3): 111-6, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25997535
6.
Explaining the appeal for immigrant men who have sex with men of a community-based rapid HIV-testing site in Montreal (Actuel sur Rue).
AIDS Care
; 27(9): 1098-103, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25849524
7.
Factors associated with the frequency of monitoring of liver enzymes, renal function and lipid laboratory markers among individuals initiating combination antiretroviral therapy: a cohort study.
BMC Infect Dis
; 15: 453, 2015 Oct 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-26496954
8.
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada.
BMC Infect Dis
; 15: 274, 2015 Jul 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-26183704
9.
Magnitude of virologic blips is associated with a higher risk for virologic rebound in HIV-infected individuals: a recurrent events analysis.
J Infect Dis
; 205(8): 1230-8, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22438396
10.
Feminizing hormone therapy in a Canadian cohort of transgender women with and without HIV.
Antivir Ther
; 28(3): 13596535231182505, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37289725
11.
Abacavir/lamivudine fixed-dose combination with ritonavir-boosted darunavir: a safe and efficacious regimen for HIV therapy.
HIV Clin Trials
; 13(6): 335-42, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23195671
12.
Trends in Use of Combination Antiretroviral Therapy and Treatment Response from 2000 to 2016 in the Canadian Observational Cohort (CANOC): A Longitudinal Cohort Study.
Can J Hosp Pharm
; 75(4): 309-316, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36246433
13.
Neighbourhood-level material deprivation and response to combination antiretroviral therapy in the Canadian Observational Cohort (CANOC): a longitudinal cohort study.
CMAJ Open
; 10(1): E183-E189, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35292476
14.
Clinical and demographic predictors of antiretroviral efficacy in HIV-HBV co-infected patients.
J Assoc Med Microbiol Infect Dis Can
; 6(2): 137-148, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36341035
15.
Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries.
BMC Infect Dis
; 10: 40, 2010 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-20184766
16.
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIV.
Medicine (Baltimore)
; 99(47): e23335, 2020 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-33217873
17.
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World Data.
Open Forum Infect Dis
; 7(11): ofaa404, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-33204746
18.
Characterization of drug resistance in antiretroviral-treated patients infected with HIV-1 CRF02_AG and AGK subtypes in Mali and Burkina Faso.
Antivir Ther
; 13(1): 141-8, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18389909
19.
A comparison of virological suppression and rebound between Indigenous and non-Indigenous persons initiating combination antiretroviral therapy in a multisite cohort of individuals living with HIV in Canada.
Antivir Ther
; 22(4): 325-335, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-27925609
20.
Increased mortality among Indigenous persons in a multisite cohort of people living with HIV in Canada.
Can J Public Health
; 108(2): e169-e175, 2017 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-28621653